166 related articles for article (PubMed ID: 3366160)
1. Reduction by cimetropium bromide of the colonic motor response to eating in patients with the irritable bowel syndrome.
Lanfranchi GA; Bazzocchi G; Campieri M; Brignola C; Fois F; Imbimbo BP
Eur J Clin Pharmacol; 1988; 33(6):571-5. PubMed ID: 3366160
[TBL] [Abstract][Full Text] [Related]
2. Effects of cimetropium bromide on gastrointestinal transit time in patients with irritable bowel syndrome.
Passaretti S; Guslandi M; Imbimbo BP; Daniotti S; Tittobello A
Aliment Pharmacol Ther; 1989 Jun; 3(3):267-76. PubMed ID: 2520622
[TBL] [Abstract][Full Text] [Related]
3. Longterm treatment of irritable bowel syndrome with cimetropium bromide: a double blind placebo controlled clinical trial.
Dobrilla G; Imbimbo BP; Piazzi L; Bensi G
Gut; 1990 Mar; 31(3):355-8. PubMed ID: 2182401
[TBL] [Abstract][Full Text] [Related]
4. Double-blind study of a new antimuscarinic, cimetropium bromide, in patients with irritable bowel syndrome.
Ferrari A; Cavallero M; Spandre M; Gemme C; Rossini FP; Imbimbo BP
Clin Ther; 1986; 8(3):320-8. PubMed ID: 3521859
[TBL] [Abstract][Full Text] [Related]
5. Transverse and sigmoid colon motility in healthy humans: effects of eating and of cimetropium bromide.
Bassotti G; Imbimbo BP; Gaburri M; Daniotti S; Morelli A
Digestion; 1987; 37(1):59-64. PubMed ID: 3609506
[TBL] [Abstract][Full Text] [Related]
6. Oral cimetropium bromide, a new antimuscarinic drug, for long-term treatment of irritable bowel syndrome.
Centonze V; Imbimbo BP; Campanozzi F; Attolini E; Daniotti S; Albano O
Am J Gastroenterol; 1988 Nov; 83(11):1262-6. PubMed ID: 3055943
[TBL] [Abstract][Full Text] [Related]
7. Colonic myoelectrical activity in irritable-bowel syndrome. Effect of eating and anticholinergics.
Sullivan MA; Cohen S; Snape WJ
N Engl J Med; 1978 Apr; 298(16):878-83. PubMed ID: 345122
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of pinaverium bromide therapy on colonic motility disorders in irritable bowel syndrome].
Wittmann T; Fehér A; Rosztóczy A; Jánosi J
Orv Hetil; 1999 Feb; 140(9):469-73. PubMed ID: 10204402
[TBL] [Abstract][Full Text] [Related]
9. Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide.
Narducci F; Bassotti G; Granata MT; Pelli MA; Gaburri M; Palumbo R; Morelli A
Dig Dis Sci; 1986 Mar; 31(3):241-6. PubMed ID: 3948628
[TBL] [Abstract][Full Text] [Related]
10. Motor effects of locally administered pinaverium bromide in the sigmoid tract of patients with irritable bowel syndrome.
Passaretti S; Sorghi M; Colombo E; Mazzotti G; Tittobello A; Guslandi M
Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):47-50. PubMed ID: 2744907
[TBL] [Abstract][Full Text] [Related]
11. Octylonium bromide in the treatment of the irritable bowel syndrome: a clinical-functional study.
Baldi F; Longanesi A; Blasi A; Monello S; Cestari R; Missale G; Corazziari E; Badiali G; Marzio L; Di Felice F
Hepatogastroenterology; 1992 Oct; 39(5):392-5. PubMed ID: 1459516
[TBL] [Abstract][Full Text] [Related]
12. Clinical and functional evaluation of the efficacy of otilonium bromide: a multicenter study in Italy.
Baldi F; Longanesi A; Blasi A; Monello S; Cestari R; Missale G; Corazziari E; Badiali G; Pescatori M; Anastasio G
Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):60-3. PubMed ID: 1756285
[TBL] [Abstract][Full Text] [Related]
13. Cimetropium bromide, a new antispasmodic compound: pharmacology and therapeutic perspectives.
Scarpignato C; Bianchi Porro G
Int J Clin Pharmacol Res; 1985; 5(6):467-77. PubMed ID: 3912339
[TBL] [Abstract][Full Text] [Related]
14. Different effects of atropine and cimetropium bromide on gastric emptying of liquids and antroduodenal motor activity in man.
Imbimbo BP; Gardino L; Palmas F; Frascio M; Canepa G; Scarpignato C
Hepatogastroenterology; 1990 Apr; 37(2):242-6. PubMed ID: 2341121
[TBL] [Abstract][Full Text] [Related]
15. Are anticholinergics of use in the irritable colon syndrome?
Ivey KJ
Gastroenterology; 1975 May; 68(5 Pt 1):1300-7. PubMed ID: 1092588
[No Abstract] [Full Text] [Related]
16. [Effect of phloroglucinol on rectosigmoid motility stimulated by a test meal. Study in patients with irritable bowel syndrome].
Cargill G; Salin B; Lubin S; Kohler F; Coste T; Rautureau J
Presse Med; 1992 Jan 4-11; 21(1):19-23. PubMed ID: 1531259
[TBL] [Abstract][Full Text] [Related]
17. Cimetropium bromide: in vitro and in vivo evaluation of spasmolytic activity on human and dog colon.
Sagrada A; Schiavone A; Cefalà A; Micheletti R
Digestion; 1989; 42(3):143-50. PubMed ID: 2767345
[TBL] [Abstract][Full Text] [Related]
18. The effect of secoverine hydrochloride on stimulated sigmoid motility: a double-blind, placebo controlled cross-over study in irritable bowel syndrome.
Ehsanullah M; Lee DA; Williams T; Pollard P; Gazzard B
Br J Clin Pharmacol; 1985 Mar; 19(3):301-5. PubMed ID: 3986085
[TBL] [Abstract][Full Text] [Related]
19. Sigmoid motility in diverticular disease and the irritable bowel syndrome.
Trotman IF; Misiewicz JJ
Gut; 1988 Feb; 29(2):218-22. PubMed ID: 3345933
[TBL] [Abstract][Full Text] [Related]
20. [The effect of quaternary derivatives of scopolamine (cimetropium bromide) on intestinal motility].
Sagrada A; Schiavone A; Cervo L; Giachetti A
Boll Chim Farm; 1986 Feb; 125(2):75-9. PubMed ID: 3741647
[No Abstract] [Full Text] [Related]
[Next] [New Search]
